Alexi Vasbinder News Today

For thousands of Americans each year, a bone marrow transplant has the potential to cure diseases such as leukemias, lymphomas and immune deficiency disorders.

While lifesaving, bone marrow transplants can affect various organs, including the cardiovascular system. Researchers led by Michigan Medicine have not only de

The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held at the Heart House in Washington, D.C., Feb. 9-11, 2024. The event is offered as an interdisciplinary and interspecialty course with a robust program providing clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice.

WEDNESDAY, Jan. 4, 2023 (HealthDay News) -- Immune checkpoint inhibitor (ICI) myocarditis is associated with changes in noncardiac biomarkers, with elevated creatine phosphokinase (CPK) associated with myocarditis development and all-cause mortality, according to a study published in the December issue of JACC: CardioOncology. Alexi Vasbinder, Ph.D., R.N., from the University of Michigan in Ann Arbor,

A study led by Michigan Medicine has uncovered that suPAR, a protein, causes atherosclerosis, linking cardiovascular disease and kidney disease. The research shows potential for suPAR to be a treatment target for both conditions.

People with cardiovascular disease still have a high burden of risk factors for severe COVID

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main con

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients.

Risk factors for cardiovascular disease such as obesity, smoking and diabetes, rather than preexisting heart disease, are the main contributors to death and poor outcomes among critically ill COVID-19 patients, according to a study.

WEDNESDAY, April 13, 2022 (HealthDay News) — The correlation between diabetes mellitus (DM) and outcomes in COVID-19 is mainly mediated by hyperinflammation, as assessed by soluble urokinase plasminogen activator receptor (suPAR) levels, according to a study published online in the March issue of Diabetes Care. Alexi Vasbinder, Ph.D., R.N., from the University of Michigan in […]